Jass J R, Young P J, Robinson E M
Department of Pathology, University of Auckland School of Medicine, New Zealand.
Gut. 1992 Nov;33(11):1508-14. doi: 10.1136/gut.33.11.1508.
Three hundred and thirty six forensic necropsy specimens of large bowel were examined in order to identify subject related variables that independently predicted the following adenoma characteristics: presence, size (largest), multiplicity and high grade dysplasia. The variables were age, gender, body mass index, race (European origin versus Maori/Polynesian) and presence of hyperplastic (metaplastic) polyp(s). Subjects included 303 New Zealanders of European origin (M = 185, F = 118) yielding 149 adenomas and 251 hyperplastic polyps and 33 Maori/Polynesians (M = 25, F = 8) yielding five adenomas and one hyperplastic polyp. Independent predictors of adenoma presence as determined by regression analysis were age (p = 0.0001), presence of hyperplastic polyps (p = 0.0001) and male gender (p = 0.05). Models were poor at explaining variation in size, multiplicity, and dysplasia. Larger adenomas occurred more frequently in subjects with multiple adenomas (p = 0.03) and multiple adenomas were probably associated with hyperplastic polyps (p = 0.09) and male gender (p = 0.09) in Europeans. High grade dysplasia was more frequent in women (p = 0.05) and possibly in subjects with hyperplastic polyps (p = 0.2). Body mass index and ethnicity did not predict any adenoma characteristics, but hyperplastic polyp prevalence was influenced by European origin (p = 0.04) and to a lesser extent by body mass index (p = 0.08) as well as presence of adenoma (p = 0.0002) and age ( = 0.005). The association of hyperplastic polyp with presence, multiplicity but not size of adenoma and with a high risk group for colorectal cancer (New Zealanders of European origin) suggests that the hyperplastic polyp serves as a marker for a factor which influences neoplastic evolution at the stages of initiation/transformation but not promotion. Fifty nine per cent of individuals with adenoma(s) did not have hyperplastic polyp(s) emphasising that the last would serve only as a marker of populations and not individuals at high risk of bowel cancer. Low intracolonic butyrate may be the factor linking the expression of the two types of polyp.
对336份大肠法医尸检标本进行了检查,以确定与受试者相关的变量,这些变量可独立预测以下腺瘤特征:是否存在、大小(最大)、多发性和高级别发育异常。变量包括年龄、性别、体重指数、种族(欧洲裔与毛利人/波利尼西亚人)以及是否存在增生性(化生)息肉。受试者包括303名欧洲裔新西兰人(男性 = 185人,女性 = 118人),共发现149个腺瘤和251个增生性息肉,以及33名毛利人/波利尼西亚人(男性 = 25人,女性 = 8人),共发现5个腺瘤和1个增生性息肉。通过回归分析确定的腺瘤存在的独立预测因素为年龄(p = 0.0001)、增生性息肉的存在(p = 0.0001)和男性性别(p = 0.05)。模型在解释大小、多发性和发育异常的变异方面效果不佳。较大的腺瘤在患有多个腺瘤的受试者中更常见(p = 0.03),在欧洲人中,多个腺瘤可能与增生性息肉(p = 0.09)和男性性别(p = 0.09)有关。高级别发育异常在女性中更常见(p = 0.05),在患有增生性息肉的受试者中可能也更常见(p = 0.2)。体重指数和种族并不能预测任何腺瘤特征,但增生性息肉的患病率受欧洲裔影响(p = 0.04),在较小程度上受体重指数影响(p = 0.08),以及受腺瘤的存在(p = 0.0002)和年龄影响(p = 0.005)。增生性息肉与腺瘤的存在、多发性而非大小相关,并且与结直肠癌的高危人群(欧洲裔新西兰人)相关,这表明增生性息肉作为一种影响肿瘤起始/转化阶段而非促进阶段肿瘤演变的因素的标志物。59%的腺瘤患者没有增生性息肉,这强调了增生性息肉仅作为人群而非个体患肠癌高风险的标志物。结肠内丁酸水平低可能是连接这两种息肉表达的因素。